Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikao Morimoto

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Arerugi = [Allergy]|December 20, 2003
[Effect of H1 histamine receptor antagonists on T cell functions]Chikao Morimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]Chikao Morimoto, Kei Ohnuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[CD26 and its signaling pathway]Kei Ohnuma, Chikao Morimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Targeted therapy by monoclonal antibodies]Kei Ohnuma, Chikao Morimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]Chikao Morimoto, Kei Ohnuma
Biochemistry and Biophysics Reports|November 21, 2018
Effects of repetitive transcranial magnetic stimulation on ER stress-related genes and glutamate, γ-aminobutyric acid and glycine transporter genes in mouse brainTetsurou Ikeda, Satoru Kobayashi, Chikao Morimoto
Data in Brief|June 8, 2018
Gene expression microarray data from mouse CBS treated with rTMS for 30 days, mouse cerebrum and CBS treated with rTMS for 40 daysTetsurou Ikeda, Satoru Kobayashi, Chikao Morimoto
Data in Brief|November 22, 2017
Gene expression microarray data from mouse cerebrum treated with rTMS for 30 daysTetsurou Ikeda, Satoru Kobayashi, Chikao Morimoto
Nature Immunology|July 22, 2015
DPP4 in anti-tumor immunity: going beyond the enzymeKei Ohnuma, Ryo Hatano, Chikao Morimoto
Trends in Immunology|May 6, 2008
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionKei Ohnuma, Nam H Dang, Chikao Morimoto
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Arerugi = [Allergy]|December 20, 2003
[Effect of H1 histamine receptor antagonists on T cell functions]Chikao Morimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]Chikao Morimoto, Kei Ohnuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[CD26 and its signaling pathway]Kei Ohnuma, Chikao Morimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Targeted therapy by monoclonal antibodies]Kei Ohnuma, Chikao Morimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]Chikao Morimoto, Kei Ohnuma
Biochemistry and Biophysics Reports|November 21, 2018
Effects of repetitive transcranial magnetic stimulation on ER stress-related genes and glutamate, γ-aminobutyric acid and glycine transporter genes in mouse brainTetsurou Ikeda, Satoru Kobayashi, Chikao Morimoto
Data in Brief|June 8, 2018
Gene expression microarray data from mouse CBS treated with rTMS for 30 days, mouse cerebrum and CBS treated with rTMS for 40 daysTetsurou Ikeda, Satoru Kobayashi, Chikao Morimoto
Data in Brief|November 22, 2017
Gene expression microarray data from mouse cerebrum treated with rTMS for 30 daysTetsurou Ikeda, Satoru Kobayashi, Chikao Morimoto
Nature Immunology|July 22, 2015
DPP4 in anti-tumor immunity: going beyond the enzymeKei Ohnuma, Ryo Hatano, Chikao Morimoto
Trends in Immunology|May 6, 2008
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionKei Ohnuma, Nam H Dang, Chikao Morimoto
Pageof 15